Test your Knowledge
Welcome to the NBCRNA’s Question of the Week page. The question of the week (QOTW) serves as an extension of the NBCRNA’s CPCA Practice and allows for CRNA’s to become familiar with question types and content while testing their knowledge. Each week a new question will be posted on Facebook and Twitter, with the answer(s) and rationale provided here. Be sure to follow NBCRNA on social media and never miss a question!
How did you do on this week's QOTW?
Rationale: Succinylcholine is contraindicated in multiple sclerosis, malignant hyperthermia, and severe sepsis. Myasthenia gravis is not a contraindication for succinylcholine administration and may present resistance.
Learn more about CPCA Practice. Up to two Class A credits available.